Advertisement

Advancing Wilson Disease Care: Evolving Approaches for Copper Control - Episode 14

Real-World Evidence and Strategies for Long-Term Adherence in Wilson Disease

Published on: 
, ,

New ATP7B gene therapies aim to normalize copper in Wilson’s disease, reducing chelation needs while raising durability and patient-selection questions.

In this episode, 'Real-World Evidence and Strategies for Long-Term Adherence in Wilson Disease,' the experts explore the complexities of maintaining treatment compliance in a lifelong chronic condition. Dr. Rima Fawaz addresses the "grave and irreversible" consequences of non-adherence, particularly for patients with neurological presentations. She notes a unique challenge in hepatic-focused cases, where a lack of daily symptoms can lead to a false sense of security, resulting in treatment gaps that may eventually trigger acute liver failure or decompensation. The panel specifically identifies the "desire to be normal" as a major hurdle for pediatric and adolescent patients, who often struggle with dietary restrictions and the social stigma of frequent medication.

The discussion shifts to a review of data from the AASLD Liver Meeting, which demonstrated a high medication adherence rate (84% of days covered) for patients treated with trientine tetrahydrochloride. Dr. Peter Hedera emphasizes that these findings are "data-driven" evidence that convenience directly correlates with clinical success. He highlights that removing technical barriers—such as the need for refrigeration or the shift from thrice-daily to twice-daily dosing—provides tangible benefits for students and active adults.

Concluding the segment, the panelists reflect on the psychological components of adherence, noting that even patients with medical backgrounds can relapse if they stop treatment because they "feel okay." The experts agree that while clinical trials establish efficacy, real-world evidence is essential for understanding how subtle changes in drug formulation can lead to profound improvements in long-term patient stability and quality of life.

The next episode in this series, 'The Multidisciplinary Approach to Patient Counseling and Care Transitions in Wilson Disease,' features the panelists advancing their conversation on Wilson disease and focusing on the essential role of longitudinal education. The experts discuss tailored counseling strategies to combat treatment burnout, the logistical hurdles of transitioning from pediatric to adult care, and how center-of-excellence models utilize multidisciplinary teams to prevent patients from falling through the cracks.

Advertisement
Advertisement